We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMXI icon
12276
PUT
International Money Express
IMXI
$441M
$27.1K ﹤0.01%
1,600
-7,900
-83% -$159K
FDVV icon
12277
PUT
Fidelity High Dividend ETF
FDVV
$10.5B
$27K ﹤0.01%
+700
New +$28.2K
NXDT
12278
PUT
NexPoint Diversified Real Estate Trust
NXDT
$271M
$27K ﹤0.01%
+3,100
New +$33.1K
ACXP icon
12279
Acurx Pharmaceuticals
ACXP
$6.02M
$26.9K ﹤0.01%
+942
New +$36K
MYE icon
12280
PUT
Myers Industries
MYE
$1.24B
$26.9K ﹤0.01%
1,500
-3,800
-72% -$71.5K
PSTX
12281
PUT
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$26.9K ﹤0.01%
11,300
-8,700
-44% -$18.2K
BIS icon
12282
PUT
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.09M
$26.9K ﹤0.01%
600
+350
+140% +$14.7K
TVRD
12283
PUT
Tvardi Therapeutics
TVRD
$25.3M
$26.9K ﹤0.01%
444
+188
+73% +$17.6K
RMNI icon
12284
PUT
Rimini Street
RMNI
$466M
$26.8K ﹤0.01%
12,200
+2,800
+30% +$8.5K
NVRI icon
12285
PUT
Enviri
NVRI
$579M
$26.7K ﹤0.01%
3,700
+1,000
+37% +$8.08K
MYPS icon
12286
PUT
PLAYSTUDIOS Inc
MYPS
$63.1M
$26.7K ﹤0.01%
8,400
-700
-8% -$2.78K
JOAN
12287
CALL
DELISTED
JOANN, Inc. Common Stock
JOAN
$26.7K ﹤0.01%
37,100
-8,900
-19% -$9.44K
SEEL
12288
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$26.7K ﹤0.01%
38
+19
+100% +$81.5K
MTA
12289
PUT
Metalla Royalty & Streaming
MTA
$912M
$26.6K ﹤0.01%
8,700
-17,000
-66% -$69.2K
ORIC icon
12290
CALL
Oric Pharmaceuticals
ORIC
$1.44B
$26.6K ﹤0.01%
4,400
-5,000
-53% -$41K
EPIX
12291
CALL
DELISTED
ESSA Pharma
EPIX
$26.6K ﹤0.01%
8,600
+4,300
+100% +$12.4K
MF
12292
DELISTED
Missfresh Limited American Depositary Shares
MF
$26.6K ﹤0.01%
+29,093
New +$27.8K
TCS
12293
CALL
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$26.6K ﹤0.01%
787
-373
-32% -$14.9K
GRFS
12294
CALL
Grifois
GRFS
$5.29B
$26.5K ﹤0.01%
2,900
-22,600
-89% -$221K
AESI icon
12295
Atlas Energy Solutions
AESI
$1.56B
$26.5K ﹤0.01%
+1,190
New +$24.9K
GWRS icon
12296
PUT
Global Water Resources
GWRS
$248M
$26.3K ﹤0.01%
2,700
-4,300
-61% -$50.5K
ELP
12297
CALL
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$26.3K ﹤0.01%
3,750
-19,625
-84% -$136K
HITI
12298
CALL
High Tide
HITI
$206M
$26.3K ﹤0.01%
14,200
+1,800
+15% +$2.57K
LTRX icon
12299
PUT
Lantronix
LTRX
$289M
$26.3K ﹤0.01%
5,900
+1,900
+48% +$8.34K
LODE icon
12300
CALL
Comstock
LODE
$263M
$26.2K ﹤0.01%
6,400
-1,900
-23% -$9.87K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.